Illumina

Illumina

Yahoo Finance • 17 hours ago

Should You Add Illumina Stock to Your Portfolio Now?

Illumina Inc. ILMN is well positioned for growth in the coming quarters, driven by strategic execution focused on growing its core sequencing business, expanding multiomics and developing services, data and software capabilities. Ongoing m... Full story

Yahoo Finance • yesterday

Top Research Reports for Goldman Sachs, TotalEnergies & Prologis

Thursday, August 27, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Goldman Sachs Group, Inc. (GS), TotalEnergi... Full story

Yahoo Finance • 4 days ago

Cancer Vaccine Breakthrough Lifts 5 Biotech Names. Here’s Who’s Best Positioned.

Quick Read MRK and MRNA's intismeran autogene beat Keytruda alone on recurrence-free survival in Phase 3 melanoma, though no specific efficacy numbers have been released yet. BNTX surged 21% on read-across excitement, while ILMN rose 16%... Full story

Yahoo Finance • 4 days ago

Should JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) Be on Your Investing Radar?

If you're interested in broad exposure to the Mid Cap Blend segment of the US equity market, look no further than the JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME), a passively managed exchange traded fund launched on May 11,... Full story

Yahoo Finance • 23 days ago

Standard BioTools Reports Second Quarter 2026 Financial Results

Standard BioTools Inc. BOSTON, Mass., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the "Company" or "Standard BioTools") today announced financial results for the quarter ended June 30, 2026. Recent Highlights:... Full story

Yahoo Finance • 24 days ago

Illumina (ILMN) Rose on Strong Clinical Momentum

Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its "Mid Cap Strategy". A copy of the Q2 2026 investor letter can be downloaded here. In the quarter, equity markets posted strong re... Full story

Yahoo Finance • 24 days ago

Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls

Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as c... Full story

Yahoo Finance • 26 days ago

Illumina (ILMN) Could Be 19% Overvalued Following Its Q2 Beat And Guidance Raise

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Illumina (ILMN) is back in focus after its Q2 2026 results beat expectations on both revenue and earnings, prompting the co... Full story

Yahoo Finance • 27 days ago

Is Grail (GRAL) Stock a Buy, Sell, or Hold at Under $70?

Grail (NASDAQ: GRAL), which was spun off from Illumina (NASDAQ: ILMN) in 2024, reached a record high of $116.06 on Jan. 22. But today, the cancer test developer's stock trades at just under $70. Is it a buy, sell, or hold at these levels?I... Full story

Yahoo Finance • 30 days ago

Scale AI taps former Google Cloud executive as CEO

July 30 - Scale AI said on Thursday it had named former Google Cloud executive Francis DeSouza as ‌chief executive officer, effective August 10, as the ‌AI company looks to expand its data and applications businesses. DeSouza will succeed... Full story

Yahoo Finance • last month

Cathie Wood's Ark Invest boosts stakes in Tesla, SpaceX, Meta, trimming Figma, Shopify

Cathie Wood’s ARK Invest’s largest purchase during July 20-24 was Tesla (TSLA [https://seekingalpha.com/symbol/TSLA]), with the firm acquiring an additional $52.7M stake after a steep sell-off post weaker-than-expected Q2 earnings report.... Full story

Yahoo Finance • last month

Earnings week ahead: AAPL. MSFT, AMZN, META, XOM, PYPL, CVX, F, KO, ABBV, V, QCOM, BA, MO, SOFI, and more

[Business Person Reviewing Quarterly Report During Meeting in Office Setting] As earnings season reaches one of its busiest and most consequential weeks, investors will be watching a broad lineup of corporate bellwethers spanning technolo... Full story

Yahoo Finance • last month

AstraZeneca (LSE:AZN) And The Valuation Case Behind Its Drug Pipeline Narrative

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. AstraZeneca (LSE:AZN) has been in focus after Illumina highlighted progress on the Billion Cell Atlas alliance. AstraZeneca is a f... Full story

Yahoo Finance • last month

3 Healthcare Stocks with Questionable Fundamentals

3 Healthcare Stocks with Questionable Fundamentals Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have realized strong financial performance, and o... Full story

Yahoo Finance • last month

Fishbone Advisors Survey: Institutional Investors See Healthcare's AI Story as Overblown

Quarterly survey of 75 institutional investors active in healthcare delivers the first published, investor-assigned AI scores for 30 large-cap healthcare companies; Eli Lilly, UnitedHealth and Moderna lead Study highlights: In every heal... Full story

Yahoo Finance • last month

Cathie Wood Dumps $39 Million Worth of AMD Stock

This article first appeared on GuruFocus. Cathie Wood's ARK Invest reduced its position in Advanced Micro Devices (NASDAQ:AMD) during the week ended July 17, making the chipmaker its largest sale of the period. ARK sold approximately $39... Full story

Yahoo Finance • last month

Cancer Biomarkers Market to Reach US$ 54.48 Billion by 2032 as Precision Oncology and Multi-Omics Adoption Accelerate

Company Logo Asia-Pacific will be the fastest-growing region. Key players include Roche, Thermo Fisher, Illumina, Agilent Technologies, and QIAGEN. Cancer Biomarkers MarketCancer Biomarkers Market Dublin, July 17, 2026 (GLOBE NEWSWIRE)... Full story

Yahoo Finance • 2 months ago

Cathie Wood Loads Up on SpaceX, Meta, Eli Lilly and Circle Group

This article first appeared on GuruFocus. Cathie Wood's ARK Invest increased positions in several technology, healthcare and digital asset companies during the week ended July 10, while reducing holdings in select semiconductor and genomi... Full story

Yahoo Finance • 2 months ago

Cathie Wood reshuffles portfolio ahead of Q2, buys SpaceX, Eli Lilly, Meta; pares AMD, Roku

Cathie Wood's ARK Invest's largest purchase during the last week by value was Elon Musk's Space Exploration Technologies (SPCX [https://seekingalpha.com/symbol/SPCX]), adding a combined 349K shares across ARKK, ARKQ, ARKW and ARKX for ~$52... Full story

Yahoo Finance • 2 months ago

Q2 watchlist: Healthcare stocks with perfect EPS revision scores

[Heart Health Concept] Eoneren/E+ via Getty Images As Q2 2026 earnings season approaches, healthcare stocks are drawing investor attention as markets assess demand across care delivery, diagnostics, life sciences, pharmaceuticals, medical... Full story